Calamos Advisors’s AEON Biopharma Inc AEON.WS Stock Holding History

Calamos Advisors’s Portfolio AEON.WS Stock Details AEON.WS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-83,333	Closed	-$121K	–	1025
2024 Q1	$121K	Hold	83,333	–	–	﹤0.01%	795
2023 Q4	$7.28K	Hold	83,333	–	–	﹤0.01%	868
2023 Q3	$12.5K	Hold	83,333	–	–	﹤0.01%	855
2023 Q2	$7.5K	Hold	83,333	–	–	﹤0.01%	933
2023 Q1	$5.46K	Hold	83,333	–	–	﹤0.01%	1096
2022 Q4	$3.8K	Hold	83,333	–	–	﹤0.01%	1164
2022 Q3	$6K	Buy	+83,333	New	+$7.61K	﹤0.01%	1203

Calamos Advisors's AEON.WS Position: Q2 2024 in Review

Calamos Advisors sold out of AEON Biopharma Inc (AEON.WS) in Q2 2024, closing a stake of 83,333 shares — an estimated $121K sold.

Calamos Advisors first reported a position in AEON.WS in Q3 2022 and held it in 7 quarters. The position peaked at $121K in Q1 2024. 0 funds tracked by Wall St. Rank hold AEON.WS as of Q2 2024.

Calamos Advisors reported no remaining AEON Biopharma Inc position as of Q2 2024 after selling out during the quarter.
Calamos Advisors sold 83,333 AEON Biopharma Inc shares in Q2 2024, an estimated $121K.
Calamos Advisors first reported a position in AEON Biopharma Inc in Q3 2022 and held it in 7 quarters.
Calamos Advisors's AEON Biopharma Inc position peaked at $121K in Q1 2024.
0 funds tracked by Wall St. Rank held AEON Biopharma Inc as of Q2 2024.

Based on Calamos Advisors's 13F filing for Q2 2024, filed 25 Jul 2024.